Funding Momentum

Funding momentum follows the rolling submission. The company recently closed a $402 million underwritten public offering, earmarked for commercialization plans and pipeline expansion. Investor engagement is bolstered by a scheduled presentation at the Deutsche Bank American Depositary Receipt (ADR) Virtual Investor Conference on April 28 2026, where Chief Medical Officer Dr. Hendrick Scholl will discuss trial outcomes and commercialization strategy. An archived webcast will be available post‑conference.